Sign In
Buy QDEL
$13.60
+0.310 (+2.33%)
At Close: Jun 03, 2026
Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now
01:42pm, Tuesday, 08'th Oct 2024
QDEL's strong product portfolio raises optimism about the stock.
QuidelOrtho Appoints Lee Bowman as Chief Human Resources Officer
07:00am, Tuesday, 10'th Sep 2024
SAN DIEGO--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL) is pleased to announce the appointment of Lee Bowman as Chief Human Resources Officer (CHRO). In this pivotal role, Bowman leads Quid
Why QuidelOrtho Stock Blasted 10% Higher Today
05:25pm, Thursday, 05'th Sep 2024
An analyst became notably more bullish on the diagnostics company's prospects. He upgraded his recommendation from hold to buy.
Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now
10:46am, Tuesday, 03'rd Sep 2024
QDEL's strong product portfolio raises optimism about the stock.
QuidelOrtho Expands in Infectious Disease Testing With New FDA Nod
12:56pm, Friday, 30'th Aug 2024
QDEL announces the FDA's clearance for its VITROS syphilis assay, which boosts the company's infectious disease testing portfolio.
QuidelOrtho (QDEL) Up 3.8% Since Last Earnings Report: Can It Continue?
12:36pm, Friday, 30'th Aug 2024
QuidelOrtho (QDEL) reported earnings 30 days ago. What's next for the stock?
NEW YORK, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against QuidelOrtho Corporation (NASDAQ:
QuidelOrtho (QDEL) Q2 Earnings Beat Estimates, U.S. Sales Down
01:46pm, Thursday, 01'st Aug 2024
QuidelOrtho's (QDEL) second-quarter results reflect growth in revenues. However, gross profit continues to decline.
QuidelOrtho Corporation (QDEL) Q2 2024 Earnings Call Transcript
09:02pm, Wednesday, 31'st Jul 2024
QuidelOrtho Corporation (NASDAQ:QDEL ) Q2 2024 Earnings Conference Call July 31, 2024 5:00 PM ET Company Participants Juliet Cunningham - Vice President-Investor Relations Brian Blaser - President & C
QuidelOrtho (QDEL) Reports Q2 Loss, Tops Revenue Estimates
07:46pm, Wednesday, 31'st Jul 2024
QuidelOrtho (QDEL) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.21. This compares to earnings of $0.26 per share a year ago.
Avantor Set to Join S&P MidCap 400; QuidelOrtho & Schneider National to Join S&P SmallCap 600
07:17pm, Tuesday, 23'rd Jul 2024
NEW YORK , July 23, 2024 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600: Avantor Inc. (NYSE:AVTR) will replace QuidelOrtho Corp. (NASD
Here's Why You Should Retain QuidelOrtho (QDEL) Stock for Now
01:26pm, Tuesday, 23'rd Jul 2024
QuidelOrtho's (QDEL) strong product portfolio raises optimism about the stock.
NEW YORK, June 24, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against QuidelOrtho Corporation (NASDAQ:
The Schall Law Firm Encourages Investors Who Have Suffered Losses In QuidelOrtho Corporation To Make Contact
04:00pm, Tuesday, 11'th Jun 2024
LOS ANGELES, CA / ACCESSWIRE / June 11, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against QuidelOrtho Corporation ("QuidelO
DEADLINE TODAY: The Schall Law Firm Encourages Investors in QuidelOrtho Corporation with Losses to Contact the Firm
10:30am, Tuesday, 11'th Jun 2024
LOS ANGELES--(BUSINESS WIRE)--DEADLINE TODAY: The Schall Law Firm Encourages Investors in QuidelOrtho Corporation with Losses to Contact the Firm.
